Last quarter (Q4 2023), Taro Pharmaceutical's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Taro Pharmaceutical's net income was $―. See Taro Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ 430.43M	$ 572.95M	$ 561.33M	$ 548.97M	$ 644.77M	$ 669.89M
Cost of Revenue	$ 224.51M	$ 304.63M	$ 268.21M	$ 252.31M	$ 245.04M	$ 224.17M
Gross Profit	$ 205.91M	$ 268.32M	$ 293.12M	$ 296.66M	$ 399.73M	$ 445.72M
Operating Expense	$ 177.47M	$ 250.61M	$ 168.22M	$ 151.51M	$ 153.19M	$ 149.53M
Operating Income	$ 28.44M	$ 17.71M	$ 124.91M	$ 145.15M	$ 246.53M	$ 296.19M
Net Non Operating Interest Income Expense	$ 8.89M	$ 15.28M	$ 15.33M	$ 20.17M	$ 33.64M	$ 33.54M
Other Income Expense	$ -1.17M	$ -20.50M	$ -14.40M	$ -556.40M	$ 17.86M	$ 27.12M
Pretax Income	$ 36.16M	$ 38.21M	$ 77.86M	$ -391.07M	$ 298.04M	$ 356.85M
Tax Provision	$ -2.51M	$ 12.77M	$ 19.59M	$ 9.67M	$ 53.48M	$ 74.73M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 38.67M	$ 25.45M	$ 58.27M	$ -386.65M	$ 244.24M	$ 281.78M
Basic EPS	$ 1.03	$ 0.68	$ 1.55	$ -10.12	$ 6.35	$ 7.23
Diluted EPS	$ 1.03	$ 0.68	$ 1.55	$ -10.12	$ 6.35	$ 7.23
Basic Average Shares	$ 112.76M	$ 37.58M	$ 37.64M	$ 38.21M	$ 38.46M	$ 38.99M
Diluted Average Shares	$ 112.76M	$ 37.58M	$ 37.64M	$ 38.21M	$ 38.46M	$ 38.99M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	$ 3.70	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 401.99M	$ 555.24M	$ 436.43M	$ 403.82M	$ 398.23M	$ 373.70M
Net Income From Continuing And Discontinued Operation	$ 38.67M	$ 25.45M	$ 58.27M	$ -386.65M	$ 244.24M	$ 281.78M
Normalized Income	$ 40.27M	-	-	$ 21.63M	$ 232.07M	$ 261.76M
Interest Expense	-	-	-	$ 1.36M	$ 725.00K	$ 256.00K
EBIT	$ 28.44M	$ 38.21M	$ 62.52M	$ -389.71M	$ 298.76M	$ 357.11M
EBITDA	$ 49.10M	$ 70.34M	$ 88.44M	$ -366.03M	$ 320.14M	$ 375.71M

Currency in USD

Taro Pharmaceutical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing